Aluminum phosphide poisoning. Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
Conditions
Interventions
Intervention 1: Intervention group: sevelamer, in addition to routine treatment, 2 tablets of 800 mg every 8 hours. Intervention 2: Control group: Receiving standard aluminum phosphide treatment witho
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Taking the oral form of aluminum phosphide Referral to Luqman Hospital within 24 hours The presence of symptoms consistent with poisoning Positive silver nitrate test Carbon monoxide measurement above 10 in non-smokers
Exclusion criteria
Exclusion criteria: glomerular filtration rate less than 30 History of kidney failure History of liver failure History of acute myocardial infarction History of congenital heart disease History of heart failure during pregnancy and breastfeeding Referral after 24 hours of taking rice tablets
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prognosis of patients poisoned with aluminum phosphide tablets referred to Luqman Hakim Hospital. Timepoint: Length of hospitalization. Method of measurement: Days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality. Timepoint: Patient death or patient survival. Method of measurement: Yes or no. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPeyman Erfantalab Avini
Shahid Beheshti University of Medical Sciences
Outcome results
None listed